Back to Search
TAYLOR HUGHES, PHARMD
PHARMD
Pharmacist
NPI: 1780288381Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Regulation of axin2 expression at the levels of transcription, translation and protein stability in lung and colon cancer.
PMID 15885887·Cancer Lett·2006
8-other
Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
PMID 16324916·Metabolism·2006
2-rct
Cross-talk between pRb/E2F and Wnt/beta-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death.
PMID 15572025·Exp Cell Res·2005
7-preclinical
Expression of axin2 is regulated by the alternative 5'-untranslated regions of its mRNA.
PMID 15611123·J Biol Chem·2005
8-other
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia.
PMID 19679883·Haematologica·2010
3-trial
Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
PMID 19679181·Brain Behav Immun·2010
7-preclinical
Dasatinib-associated major molecular responses in patients with chronic myeloid leukemia in chronic phase following imatinib failure: response dynamics and predictive value.
PMID 19641527·Leukemia·2009
8-other
An evaluation of maxillary and mandibular rotational responses with the Clark twin block appliance.
PMID 19634464·Aust Orthod J·2009
8-other
Metabolic implications of dietary trans-fatty acids.
PMID 19584878·Obesity (Silver Spring)·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1301 DORCHESTER RD
CHATTANOOGA, TN 37405 - Phone
- (423) 267-5060
Quick Facts
- NPI
- 1780288381
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile